Cite
Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial
MLA
Tomaniak, Mariusz, et al. Impact of Renal Function on Clinical Outcomes after PCI in ACS and Stable CAD Patients Treated with Ticagrelor: A Prespecified Analysis of the GLOBAL LEADERS Randomized Clinical Trial. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f8861b285f1d60eb1ffe3969fb187875&authtype=sso&custid=ns315887. Accessed 1 Nov. 2024.
APA
Tomaniak, M., Chichareon, P., Klimczak-Tomaniak, D., Takahashi, K., Kogame, N., Modolo, R., Wang, R., Ono, M., Hara, H., Gao, C., Kawashima, H., Rademaker-Havinga, T., Garg, S., Curzen, N., Haude, M., Kochman, J., Gori, T., Montalescot, G., Angiolillo, D. J., … Anderson, R. (n.d.). Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
Chicago
Tomaniak, Mariusz, Ply Chichareon, Dominika Klimczak-Tomaniak, Kuniaki Takahashi, Norihiro Kogame, Rodrigo Modolo, Rutao Wang, et al. 2024. “Impact of Renal Function on Clinical Outcomes after PCI in ACS and Stable CAD Patients Treated with Ticagrelor: A Prespecified Analysis of the GLOBAL LEADERS Randomized Clinical Trial.” Accessed November 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f8861b285f1d60eb1ffe3969fb187875&authtype=sso&custid=ns315887.